Pharmaresearch, a leading regenerative medicine company, participated in the recent KORA (Korean Society for Aesthetic Obesity Regenerative Medicine) conference held on the 11th. At the conference, Pharmaresearch showcased the clinical value and differentiated offerings of its aesthetic product lineup.
The company structured an in-depth academic program centered around its core aesthetic products, including Rejuran (PN), Rejuviel (HA), and Evercle (PLLA), which garnered significant interest from attending medical professionals. Discussions included the latest insights and refined procedural protocols, particularly in light of trends in aesthetic medicine.
Notable presentations featured experts sharing clinical cases. Dr. Kim So-eun from So Eun Clinic discussed the theme "Post-GLP-1 Treatment: Facial Volume Loss and Aging Changes. Prevention and Improvement Strategies Using PN," highlighting the skin regeneration and environmental mechanisms provided by PN (poly nucleotide) in response to significant weight loss.
Dr. Kim Do-wi from Esribon Clinic emphasized the importance of safety and durability in filler procedures, going beyond mere volume creation. He shared advanced techniques utilizing the highly viscous Rejuviel C line, emphasizing its superior properties and high-purity raw materials that maintain robust support without shape distortion.
Dr. Lee Kyung-eun from The Ann Cheongdam Clinic presented on the utilization of Evercle, a next-generation PLLA formulation, demonstrating its natural volume restoration and skin regeneration effects. Her clinical case presentations showed how Evercle promotes autologous collagen production, leading to simultaneous improvements in facial volume and skin texture.
In addition to the academic sessions, Pharmaresearch also promoted its aesthetic distribution platform, TheMicro, at an on-site booth. This platform recently underwent intuitive updates, enhancing product ordering and management convenience and receiving positive feedback from medical professionals for its commitment to a transparent and secure genuine product distribution ecosystem.
A Pharmaresearch spokesperson stated that the KORA conference represented an important opportunity to share the company's robust aesthetic portfolio, including Rejuran, Rejuviel, and Evercle, with medical professionals aligned with cutting-edge aesthetic medicine trends. The company aims to continue engaging in ongoing academic exchanges to present evidence-based clinical solutions and solidify a trustworthy and reliable genuine product distribution environment through TheMicro.
